AzTrials
AzTrials

Rheumatic DiseasesNCT07274124

Pain Neuroscience Education and Vagus Nerve Stimulation on Recovery in Individuals With Rheumatoid Arthritis

A study testing Pain Neuroscience Education, Vagal Nerve Stimulation and Structured Exercises in people with Rheumatic Diseases and Rheumatoid Arthritis (RA), run by Medipol University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

In the context of this randomized controlled study, patients who are diagnosed with Rheumatoid arthritis in Cerrahpaşa Faculty of Medicine Hospital, will be taken into a rehabilitation program by a qualified physiotherapist to improve their pain, pain perception, inflammatory markers and quality of life, with one of… Read more about this study

Who is it for?
Ages 20 to 65 years
Conditions the study is for
Rheumatic Diseases, Rheumatoid Arthritis (RA)
What is being tested?
Pain Neuroscience Education, Vagal Nerve Stimulation and Structured Exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteTurkey (Türkiye)
Study dates
18 Feb 2026to Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals who were diagnosed with RA at least one year ago,
  • More than score 2.6 in DAS28,
  • Ages of 20 and 65,
  • Have been experiencing pain for three months or more,
  • Score 24 or higher on the Mini Mental State Examination (MMSE), and can follow instructions will be included in the study.

Who cannot join

  • Individuals under 20 years of age,
  • Reporting acute pain or pain from injury,
  • Having a history of surgery within the last year,
  • Remission in DAS28,
  • Patients whose medication was changed,
  • Having a score of <24 on the MMSE,
  • Having any of the cerebrovascular disease, cardiovascular disease, symptomatic coronary artery disease, myocardial infarction, congestive heart failure, or uncontrolled hyper/hypotension,
  • History of vagotomy surgery, or having an implanted electrical/neurostimulator device will not be included in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Simay AKDEMİR, MSc. Phd Candidate/Lec. contact

+905347032126

simay.akdemir@medipol.edu.tr

Ela TARAKCI, Prof. Dr. contact

+905422175730

etarakci@iuc.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Cerrahpaşa Faculty of Medicine Hospital

    Istanbul, Fatih

    Serdal UĞURLU, Prof. Dr., +905424356265, serdal.ugurlu@iuc.edu.tr

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effects of Pain Neuroscience Education and Vagus Nerve Stimulation on Recovery in Individuals With Rheumatoid Arthritis

In the context of this randomized controlled study, patients who are diagnosed with Rheumatoid arthritis in Cerrahpaşa Faculty of Medicine Hospital, will be taken into a rehabilitation program by a qualified physiotherapist to improve their pain, pain perception, inflammatory markers and quality of life, with one of the pain neuroscience education, vagal nerve stimulation and traditional exercise interventions. The results of each intervention method will be analyzed and compared at the end of the 8 weeks study protocol.

Read the detailed description

Pain, a complex and multifaceted experience, is the most common symptom observed in inflammatory arthritis. In addition to pathological events such as inflammation and tissue infection, various personal, social, and behavioral factors such as illness beliefs, mood, behavior, avoidance, sleep disturbance, and daily rest and activity status also contribute to pain and pain perception. According to the 2018 EULAR recommendations, the principles of pain management methods are based on a patient-centered care and social assistance models of rehabilitation. According to PNE, the primary cause of chronic pain is not an organ or tissue damage, but rather over activation of the central nervous system and central sensitization and the goal is to reduce CNS activation, minimize fear of movement, and increase pain tolerance, thereby supporting exercise participation. Based on the biopsychosocial model, this method aims to reduce movement and illness avoidance behavior by reshaping pain perception. It is typically presented to patients through one-on-one or group meetings, phone calls, or visual brochures. Another effective method on the indicated pain related symptoms is known as Vagal nerve stimulation. Neural regulation can be achieved by vagal nerve stimulation, which is related to the pain-processing pathways of the brain, or pain reduction can be achieved indirectly through the anti-inflammatory effect it creates. While studies in the literature on VNS mostly focus on individuals with chronic pain, fibromyalgia, abdominal pain, and headache, there are few studies on rheumatoid arthritis. Besides no studies have examined the effects of PNE. This research points to a significant deficiency in pain perception, awareness, and control in individuals with RA. Based on this information, the aim of this study was to examine the effects of pain neuroscience training and vagal nerve stimulation on healing parameters in individuals with rheumatoid arthritis and to compare the results in terms of their superiority.

Being tested
Pain Neuroscience Education, Vagal Nerve Stimulation, Structured Exercises
Keywords
rheumatoid arthritis, pain neuroscience education, vagal nerve stimulation, exercise
Medical subject headings
Rheumatic Diseases, Arthritis, Rheumatoid, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pain Neuroscience EducationOther

    Many sources in the literature draw attention to patient education as the first stage of treatment and the most common educational technique that focuses on the perception, mechanism and modulation of pain is known as Pain Neuroscience Education (PNE). Patients in this group will take educational sessions about the pain, facilitators of pain, the factors affecting the pain perception and how to deal with chronic pain in rheumatoid arthritis with the help of power point presentations, animation videos, pictures and drawings. Intervention will last for 8 weeks, 2 times per week, in total 16 sessions will be completed. Each session will last 30 minutes in average and at the same time, patients will be advised to perform the given home exercises for 2 times per week. Assessments will be performed before and after the intervention.

  • Vagal Nerve StimulationOther

    Vagus nerve (cranial nerve X) is the longest and most widely distributed cranial nerve containing sensory, motor, and parasympathetic fibers. It plays an important role in the regulation of cardiovascular, respiratory, immune, endocrine, and autonomic systems, as well as homeostasis. Participants with rheumatoid arthritis will be taken into stimulation sessions for 2 times per week for continuous 8 weeks. Assessments will be performed before study and after the 16 sessions are completed. Since the literature has missing knowledge about the effects of Vagal nerve stimulation in rheumatoid arthritis, the results will highlight the effects on pain and inflammatory markers in this population. Current will be given from the left ear/transauricular area to prevent the side effects in the sessions.

  • Structured ExercisesOther

    Structured exercise planned in this study is based on the principles and suggestions of EULAR, by consisting warm-up, basic exercise and warm up sessions by combining different exercise types like aerobic, strengthening flexibility, breathing and definitely by including hand specific exercises. Participants in all three groups will be educated in the first session about the exercises to prevent wrong application and injuries. Afterwards, all groups will continue to their exercises at the home setting. An exercise diary will be asked from patients to control if they continue to their exercises regularly for 2 times for 8 weeks.

Study groups in NCT07274124
Study groupRoleWhat they receive
Pain Neuroscience Education + Structured ExerciseExperimentalThe PNE method will be applied simultaneously with exercise. Training will begin after the first session, which includes a face-to-face assessment. On the first day, a PowerPoint presentation will introduce the patient about pain anatomy, physiology, factors affecting pain, and central and peripheral sensitization. The topic of pain will be introduced, and the patient will be informed about the process. Pain mechanisms will be reviewed using video explanations, visual aids, and animations, information will be provided on what physical activity is and its effects on pain, patients will be asked their opinions on exercise, suggestions for physical daily, living activities will be given such as increasing activity, using stairs, limiting screen time type of suggestions will be thought to the patient and the patient's wishes and goals will be questioned in the further sessions. Each session will last 30 minutes and 16 education sessions will be completed in total.
Receives: Other: Pain Neuroscience Education; Other: Structured Exercises
Vagal Nerve Stimulation + Structured ExerciseExperimentalWill be applied with the non-invasive taVNS-Research (tVNS®) device, which is the only safe auricular vagus stimulation device approved by the Ministry of Health in Türkiye and is used in various diseases such as headache, epilepsy, and fibromyalgia. Electrodes will be placed on the left auricular cavum conchae using two carbon-impregnated silicone electrodes to reduce the risk of cardiac side effects. Vagal nerve stimulation will be administered twice a week for 8 weeks, with a total of 16 supervised sessions. During this period, the home exercise intervention that patients are asked to perform will continue. Following the initial evaluation, the exercises will be taught to the patient, and the first nerve stimulation session will be performed. Current intensity will be adjusted according to the patient tolerance-threshold value, and this value will be recorded for each session.
Receives: Other: Vagal Nerve Stimulation; Other: Structured Exercises
Structured ExerciseActive comparatorThe Structured exercise intervention, specifically for individuals with RA and designed to target painful areas, will be implemented in the form of home exercises for all three groups, twice a week for 8 weeks. The exercise program will primarily consist of warm-up, basic exercise, and a cool-down period. Aerobic, strengthening, flexibility, breathing, and hand exercises will be planned based on EULAR recommendations. The warm-up period will begin with flexibility and range of motion exercises, followed by calisthenic and therapeutic endurance and strengthening exercises, and the session will ended with diaphragmatic breathing and hand exercises during the cool-down period. Additionally, walking activity will be recommended for at least two days per week.
Receives: Other: Structured Exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Catastrophizing Scale

    13-item questionnaire, based on personal feedback, assesses the severity of patients' reactions to pain on a scale of 0-4. The validity and reliability of the questionnaire in Turkish has been established.

    Measured: 8 weeks

  2. Disease Activity Score-28 (DAS28)

    Assesses disease activity in 28 different joints. Blood draws will be performed by a specialist physician who diagnoses patients, conducts regular checkups, and then refers suitable patients to a physical therapist. A score below 2.6 indicates the disease is in remission; scores between 2.6 and 3.1 indicate low disease activity; scores between 3.1 and 5.1 indicate moderate disease activity; and scores above 5.1 indicate high disease activity.

    Measured: 8 weeks

Secondary outcomes (11)
  1. Demographic Information Form

    The patient's personal information, medical treatment history, current lifestyle, and exercise habits will be inquired about using a form specifically designed for the specific disease.

    Measured: At the beginning only

  2. Mcgill Pain Questionnaire Short Form

    Developed by Melzack in 1987, the questionnaire assesses chronic pain in three sections: pain characteristics, severity, and intensity, has also been validated in Turkish and is recommended for use in rheumatological patients. The Turkish validation of the questionnaire was conducted by Yavuz et al. in 2007, and it was found to be valid in Turkish. Higher score indicates severe pain severity.

    Measured: 8 weeks

  3. Pain Algometry

    The pressure pain threshold (PPT), defined as the minimum pressure stimulus applied to elicit pain, is suitable for measuring pain in RA. Pain thresholds will be measured using an algometer at the third metacarpophalangeal (MCP) joints, the wrist, and the most inflamed joints.

    Measured: 8 weeks

  4. Pain Coping Inventory

    Indicates how frequently patients use behavioral and cognitive methods to cope with pain. The questionnaire, consisting of 6 subscales (active and passive), inquires about patients' orientations during painful situations. Items are scored on a 4-point Likert scale, with 1 being the least frequent use of pain management measures and 4 being the most frequent.

    Measured: 8 weeks

  5. Tampa Kinesiophobia Scale

    Published in 1995 to measure fear of movement and re-injury, the questionnaire consists of 17 items. Questions address areas such as fear of re-injury and avoidance of movement. A score of 17 is the lowest possible score, and indicates no kinesiophobia or negligible.

    Measured: 8 weeks

  6. Bristol Rheumatoid Arthritis Multidimensional Fatigue Questionnaire

    Examines the various dimensions of the effects of RA on fatigue. It was developed in 2010. The questionnaire consists of four subcategories: physical fatigue in the last 7 days, fatigue in activities of daily living, and cognitive and emotional fatigue. Patients receive scores between 0 and 70 on the 20-question questionnaire, with higher scores indicating higher fatigue.

    Measured: 8 weeks

  7. Pittsburgh Sleep Quality Scale

    19-item scale questions subjective sleep quality over the past month. The total score ranges from 0 to 21, with a higher score indicating poor sleep quality. A Turkish version of the scale is available and is used in rheumatological diseases.

    Measured: 8 weeks

  8. Rheumatoid Arthritis Quality of Life Scale

    30-item scale, with valid and reliable Turkish versions, is a published quality of life questionnaire specific to rheumatoid arthritis. Higher scores indicate lower quality of life.

    Measured: 8 weeks

  9. Community Integration Scale-Revised

    (CIQ-R) is a brief, standardized instrument used to assess community integration in individuals following neurological conditions. The scale consists of 14 items organized into a four-factor structure, including home integration, social integration, productive activities, and communication/electronic social networking. It evaluates participants' level of independence and engagement in daily life over the past month, with higher scores indicating greater community participation. Findings from validation studies demonstrate that the Turkish version of the CIQ-R is a valid and reliable tool for assessing community integration in individuals with stroke. The availability of this instrument supports its use in clinical practice, outcome assessment, and cross-cultural research in stroke rehabilitation.

    Measured: 8 weeks

  10. Upper and Lower Extremity Goniometry and Circumference Measurements

    To examine the relationship between pain and joint range of motion, goniometry measurements will be taken at the four most commonly affected areas: the atlantoaxial joint, shoulder joint, wrist joint, and ankle with the degree of movement.

    Circumference measurements will be taken at the hand, finger, and ankle to assess inflammation in the centimeter measures.

    Measured: 8 weeks

  11. Multiple Choice Questions and Answers

    Participants in the PNE group will be asked to answer 10 multiple-choice questions covering the presentation topics. This will provide information about the level of understanding of the information presented within the PNE group and its impact on the pain questionnaires, according to the score they take out of the total score of 100.

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2025
  2. Study start18 Feb 2026
  3. Primary completionMay 2027 (estimated)
  4. Study completionJul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study will be conducted using a randomized, controlled, prospective design. Thirty-six individuals diagnosed with RA at the Department of Rheumatology at Cerrahpaşa Faculty of Medicine Hospital will be included in the study. Following the physician referral, individuals who meet the inclusion criteria will be divided into three equal groups (12 in each), by using block randomization by the "randomizer.org" website, and the number of cases will be calculated using the "GPower" application. Demographic information will be collected before the study begins, and all participants will be informed in advance of the study's purpose, duration, and content, as well as the voluntary nature of their participation with an informed consent form. After the initial assessment, the intervention will last for 8 weeks and consist of three groups: "Pain Neuroscience Education-PNE + Structured Exercise," "Transauricular Vagus Nerve Stimulation-tVNS + Structured Exercise," and "Structured Exercise."
Masking
Single blind
Who is masked
Participant
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07274124
Sponsor's protocol ID
E-10840098-202.3.02-7253
Status last verified
Oct 2026
First submitted
19 Nov 2025
Last updated
9 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Pain Neuroscience Education, Vagal Nerve Stimulation and Structured Exercises in people with Rheumatic Diseases and Rheumatoid Arthritis (RA), run by Medipol University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Simay AKDEMİR, MSc. Phd Candidate/Lec. (+905347032126, simay.akdemir@medipol.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Catastrophizing Scale (time frame: 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in